The Coming Federal Hemp Ban — And What It Means for Legal Cannabis

What if you could buy a “non-alcoholic” beverage that got you drunk? How would this new beverage be regulated under our current laws? Well, this is the exact dilemma that the cannabis industry is currently facing.

Over the past several years, the cannabis industry has watched the “non-THC” market grow at lightning speed. Hemp-derived cannabinoids like CBG, CBN, CBC, THCV, delta-8 THC, and THCA products have flooded convenience stores, smoke shops, and online retailers nationwide. These products exist largely outside the state-regulated system — and in many states, including Washington, they’ve taken a measurable bite out of regulated THC cannabis sales.

Now the federal government is preparing to close what has commonly been called the “hemp loophole.” A major shift in federal hemp policy, signed into law in November 2025 and scheduled for enforcement beginning November 12, 2026, could dramatically reshape both the hemp and cannabis industries. For licensed cannabis producers and retailers, this moment may represent one of the most significant regulatory turning points since legalization began.

The Hemp Boom and Its Impact on Cannabis

The 2018 Farm Bill legalized hemp containing less than 0.3% delta-9 THC, but the law unintentionally created a pathway for intoxicating hemp products to flourish. Manufacturers quickly began producing hemp-derived cannabinoids that could mimic or replicate the effects of traditional THC. Products such as delta-8 cartridges, THCA flower, hemp-derived THC beverages, and cannabinoid-infused edibles became easy to purchase without visiting a licensed cannabis retailer.

At the same time, interest in so-called “minor cannabinoids” — including CBG, CBN, CBC, and THCV — has grown significantly. Many consumers have been drawn to these compounds for their perceived functional or wellness benefits, while others have turned to hemp-derived THC products simply because they are easier to access and often less expensive.

Over the past four years, Washington’s legal cannabis market has shown signs of contraction, with many operators pointing to hemp-derived products as the culprit. Across the country,  this “loophole” has created an uneven playing field by allowing hemp products to be sold outside the regulated system. Like the wild west. 

While Washington cannabis sales declined nearly 20% since 2021, hemp-derived cannabinoid sales exploded more than 1,200% nationwide during the same period.

A New Federal Definition of Hemp

The new federal law dramatically tightens the definition of legal hemp. Instead of measuring only delta-9 THC, the updated standard requires hemp to contain less than 0.3 percent total THC on a dry-weight basis. This total THC calculation includes delta-8, delta-9, THCA, and other THC isomers, closing the loophole that previously allowed intoxicating hemp products to qualify as legal.

In other words, no more “non-alcoholic” drinks that get you drunk. 

The legislation also imposes a strict limit on finished products. Hemp products will be prohibited if they contain more than 0.4 milligrams of total THC per container. This threshold is extremely low and effectively removes most currently available hemp-derived THC products from the legal market. Nearly all hemp gummies, beverages, tinctures, and vape products exceed this limit by a wide margin, meaning the vast majority of existing products would no longer qualify as legal hemp.

In addition to THC limits, the law specifically targets synthesized and chemically converted cannabinoids. Many products currently sold as hemp intoxicants are produced by converting CBD into other compounds such as delta-8 THC through laboratory processes. Under the new rules, these types of products will be prohibited. The legislation also restricts cannabinoids that do not naturally occur in meaningful concentrations in the cannabis plant, further narrowing what can be legally sold as hemp.

Although the law was signed in November 2025, enforcement will not begin until November 12, 2026. This transition period gives producers and retailers some time to prepare, but unless the law is modified, the deadline represents a hard cutoff for most intoxicating hemp products.

A Massive Industry Facing Disruption

Industry analysts estimate that the new federal rules could eliminate as much as 95 percent of the existing hemp retail market. The hemp-derived cannabinoid industry has grown into an estimated $28 billion sector, and the upcoming restrictions could represent one of the largest regulatory disruptions the cannabis space has ever experienced.

For hemp producers and retailers, the potential impact is enormous. Entire product categories could disappear almost overnight, and many businesses built around hemp-derived cannabinoids may be forced to close or dramatically restructure. For licensed cannabis operators, however, the changes may restore some balance to a marketplace that has been heavily influenced by unregulated competition.

Many cannabis companies believe that the shift could bring consumers back into licensed retail stores, where products are subject to consistent safety testing and quality standards. In mature markets like Washington, where competition is already intense and margins are tight, even a modest shift in consumer behavior could have meaningful effects.

Efforts to Delay or Modify the Ban

Despite the approaching enforcement deadline, the future of the hemp ban is not entirely settled. Several proposals have been introduced in Congress that could delay or reshape the new regulations.

Representatives Angie Craig and Jim Baird have introduced bipartisan legislation that would postpone implementation until November 2028. Supporters of the delay argue that hemp farmers and businesses need additional time to adapt and that an abrupt regulatory shift could cause unnecessary economic damage.

An alternative approach has been proposed by Senators Ron Wyden and Jeff Merkley through the Cannabinoid Safety and Regulation Act. Rather than banning hemp-derived cannabinoids outright, the proposal would establish a structured regulatory framework. The plan would include age restrictions, product testing standards, packaging requirements, and manufacturing guidelines, bringing hemp cannabinoids under a system more similar to state-licensed cannabis.

Federal officials have also indicated interest in developing broader cannabis policy reforms. The administration has directed agencies to work toward safe and regulated access to CBD products and has expressed interest in rescheduling cannabis to Schedule III. While these efforts are separate from the hemp legislation, they suggest that federal cannabis policy remains in flux.

What Comes Next

Even if the federal restrictions move forward as scheduled, some states may attempt to create their own regulatory frameworks for hemp-derived cannabinoids. However, the new federal definition of hemp would likely eliminate interstate commerce for most intoxicating hemp products, making it difficult for national brands to operate as they do today.

For licensed cannabis companies, particularly in Washington State, the coming federal hemp restrictions represent a long-awaited shift. For years, regulated cannabis businesses have competed against products that closely resemble cannabis while operating outside the licensed system. The new rules could redirect sales back into regulated markets where products are tested, labeled, and sold through licensed retailers.

The next two years will determine whether the hemp market is phased out entirely or reshaped into a more structured regulatory system. Either way, the changes coming in 2026 are likely to mark the end of the unregulated intoxicating hemp era and the beginning of a new chapter for both hemp and cannabis in the United States.